SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Efficacy and Cost-Effectiveness of Cancer Treatment: Rational Allocation of Resources Based on Decision Analysis
0 references·14 citing·38 second hop
Efficacy and Cost-Effectiveness of Cancer Treatment: Rational Allocation of Resources Based on Decision Analysis (1993)Efficacy and Cost-Effectiveness of Cancer…Willingness to Pay for Lung Cancer Treatment (2010)Willingness to Pay for Lung C…Oral cancer treatment costs in Greece and the effect of advanced disease (2002)Oral cancer treatment costs i…Decision Analysis for the Cost-Effective Management of Recurrent Colorectal Cancer (2001)Decision Analysis for the Cos…‘More than just money’– widening the understanding of the costs involved in cancer care (2001)‘More than just money’– widen…The effectiveness of cost-effectiveness analysis in containing costs (1998)The effectiveness of cost-eff…The Costs and Cost-Effectiveness of Unrelated Donor Bone Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia (1998)The Costs and Cost-Effectiven…Integrating Economic Analysis Into Cancer Clinical Trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook (1998)Integrating Economic Analysis…Health and Economic Outcomes Modeling Practices: A Suggested Framework (1998)Health and Economic Outcomes …Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. (1998)Cost-effectiveness of routine…Cost-effectiveness analysis in oncology (1998)Cost-effectiveness analysis i…A Cost-Utility Analysis of Second-Line Chemotherapy in Metastatic Breast Cancer (1996)A Cost-Utility Analysis of Se…The clinical-economic trial: Promise, problems, and challenges (1995)The clinical-economic trial: …Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer (1995)Cost-effectiveness of palliat…Cost-effectiveness of Head CT in Patients With Lung Cancer Without Clinical Evidence of Metastases (1995)Cost-effectiveness of Head CT…Markov Models in Medical Decision Making (1993)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Partial-Breast Irradiation Versus Whole-Breast Irradiation for Early-Stage Breast Cancer: A Cost-Effectiveness Analysis (2008)Hypofractionated breast radiotherapy: Financial and economic consequences (2010)Cost-Effectiveness Analysis of Intraoperative Radiation Therapy for Early-Stage Breast Cancer (2013)Theory of games and economic behavior (2019)Reporting results of cancer treatment (1981)Health-related quality of life measurement for evaluation research and policy analysis. (1982)Methods for the economic evaluation of health care programmes (1987)Equity and the economic evaluation of healthcare (2001)Cost-Effectiveness versus Cost–Utility Analysis of Interventions for Cancer: Does Adjusting for Health-Related Quality of Life Really Matter? (2004)Costs and trends in pancreatic cancer treatment (2012)Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature (1992)Economic issues in lung cancer: a review. (1998)The Markov Process in Medical Prognosis (1983)Current Trends in the Use of Pharmacoeconomics and Outcomes Research in Europe (1999)Cost Effectiveness of Treatment Options in Advanced Breast Cancer in the UK (2001)Cost‐effectiveness analysis of oxaliplatin compared with 5‐fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US (2007)Clinical decision analysis (2005)Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer. (2005)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Cost-effectiveness of a primary care depression intervention (2003)Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study (2004)Review of Eight Pharmacoeconomic Studies of the Value of Biologic DMARDs Adalimumab, Etanercept, and Infliximab) in the Management of Rheumatoid Arthritis (2006)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Qualitative Research: Consensus methods for medical and health services research (1995)Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life (1997)A nice challenge for health economics (2000)The evaluation of disease prevention and treatment using simulation models (2003)Review of modelling approaches for healthcare simulation (2016)Clinical Economics (1989)Cost-Effectiveness in Health and Medicine (1996)Economic burden of head and neck cancer (2004)Epidemiology and cost analysis for patients with oral cancer in a university hospital in China (2010)The cost of oral cancer: A systematic review (2022)A Clinician's Guide to Cost-Effectiveness Analysis (1990)Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma (2009)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 1995Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer151 cited
  • 1998The effectiveness of cost-effectiveness analysis in containing costs120 cited
  • 1998Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer.97 cited
  • 1996A Cost-Utility Analysis of Second-Line Chemotherapy in Metastatic Breast Cancer93 cited
  • 2001Decision Analysis for the Cost-Effective Management of Recurrent Colorectal Cancer83 cited
  • 1995Cost-effectiveness of Head CT in Patients With Lung Cancer Without Clinical Evidence of Metastases78 cited
  • 1998Health and Economic Outcomes Modeling Practices: A Suggested Framework70 cited
  • 1998The Costs and Cost-Effectiveness of Unrelated Donor Bone Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia59 cited
  • 2002Oral cancer treatment costs in Greece and the effect of advanced disease56 cited
  • 1995The clinical-economic trial: Promise, problems, and challenges55 cited
  • 2001‘More than just money’– widening the understanding of the costs involved in cancer care51 cited
  • 1998Cost-effectiveness analysis in oncology51 cited
  • 2010Willingness to Pay for Lung Cancer Treatment49 cited
  • 1998

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Integrating Economic Analysis Into Cancer Clinical Trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook
49 cited